Pharmacology of adenosine A(2A) receptors

Trends in Pharmacological Sciences

Volumn 17, Issue 10, 1996, Pages 364-372

  Ongini, Ennio ^a   Fredholm, Bertil B ^b  

^a San Raffaele Science Park   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINO 8 CHLORO 1 PHENYL 1,2,4 TRIAZOLO[4,3 A]QUINOXALINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 2 (2 FURYL) 7 (3 PHENYLPROPYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 8 (4 FLUOROBENZYL) 2 (2 FURYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 7 METHYL 1,3 DIPROPYL 8 [2 (3 THIENYL)ETHENYL]XANTHINE; 8 (3 CHLOROSTYRYL)CAFFEINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR AFFECTING AGENT; CAFFEINE; CYCLIC AMP; CYCLOHEXYLADENOSINE; DOPAMINE 2 RECEPTOR; N [2 (DIMETHYLAMINO)ETHYL] N METHYL 4 (1,3 DIPROPYLXANTHIN 8 YL)BENZENESULFONAMIDE; PHENYLISOPROPYLADENOSINE; RADIOLIGAND; RECEPTOR SUBTYPE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ADENOSINE RECEPTOR;

BLOOD VESSEL; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG RESEARCH; HUMAN; MAMMAL; MENTAL DISEASE; MOLECULAR CLONING; NEUROLOGIC DISEASE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; THROMBOCYTE; TISSUE DISTRIBUTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION;

ANIMALS; HUMANS; RECEPTORS, PURINERGIC P1;

EID: 0030250999     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)10045-6     Document Type: Review

References (60)

1. 1 Fredholm, B. B. et al. (1994) Pharmacol. Rev. 46, 143-156
2. 2 Jacobson, M. A. (1995) in Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology (Belardinelli, L. and Pelleg, A., eds), pp. 5-14, Kluwer Academic Publishers
3. 3 Olah, M. E. and Stiles, G. L. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 581-606
4. 4 Jacobson, K. A., van Galen, P. J. M. and Williams, M. (1992) J. Med. Chem. 35, 407-422
5. 5 Collis, M. G. and Hourani, S. M. O. (1993) Trends Pharmacol. Sci. 14, 360-366
6. 6 Baraldi, P. G. et al. (1995) Curr. Med. Chem. 2, 707-722
7. 7 van Caiker, D., Muller, M. and Hamprecht, B. (1979) J. Neurochem. 33, 999-1005
8. 8 Londos, C., Cooper, D. M. F. and Wolff, J. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 2551-2554
9. 9 Daly, J. W. (1977) in Cyclic Nucleotides in the Nervous System, pp. 1-398, Plenum Press
10. 10 Bruns, R. F., Lu, G. H. and Pugsley, T. A. (1986) Mol. Pharmacol. 29, 331-346
11. 11 Braun, S. and Levitzki, A. (1979) Biochemistry 18, 2134-2138
12. 12 Nanoff, C., Jacobson, K. A. and Stiles, G. L. (1991) Mol. Pharmacol. 39, 130-135
13. 13 Peterfreund, R. A., MacCollin, M., Gusella J. and Fink, J. S. (1996) J. Neurochem. 66, 362-368
14. 14 Barrington, W. W., Jacobson, K. A., Hutchison, A. J., Williams, M. and Stiles, G. L. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6572-6576
15. 15 Parkinson, F. E. and Fredholm, B. B. (1992) Mol. Neuropharmacol. 1, 179-186
16. 16 Chern, Y., Lai, H. L., Fong, J. C. and Liang, Y. (1993) Mol. Pharmacol. 44, 950-958
17. 17 Palmer, T. M., Gettys, T. W., Jacobson, K. A. and Stiles, G. L. (1994) Mol. Pharmacol. 45, 1082-1094
18. 18 Longabaugh, J. P., Didsbury, J., Spiegel, A. and Stiles, G. L. (1989) Mol. Pharmacol. 36, 681-688
19. 19 Fastborn, J. and Fredholm, B. B. (1990) Brain Res. 507, 195-199
20. 20 Green, A., Johnson, J. L. and Milligan, G. (1990) J. Biol. Chem. 265, 5206-5210
21. 21 Casati, C. et al. (1994). Pharmacol. Exp. Ther. 268, 1506-1511
22. 22 Adami, M., Bertorelli, R., Ferri, N., Foddi, M. C. and Ongini, E. (1995) Eur. J. Pharmacol. 294, 383-389
23. 23 Abbracchio, M. P., Fogliatto, G., Paoletti, A. M., Rovati, G. E. and Cattabeni, F. (1992) Eur. J. Pharmacol. Mol. Pharmacol. Sect. 258, 317-324
24. 24 Daly, J. W., Padgett, W., Shamim, M. T., Butts-Lamb, P. and Waters, J. (1985) J. Med. Chem. 28, 487-492
25. 25 Bruns, R. F. et al. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 59-63
26. 26 Shimada, J., Suzuki, F., Nonaka, H., Ishii, A. and Ichikawa, S. (1992) J. Med. Chem. 35, 2342-2345
27. 27 Nonaka, H. et al. (1994) Eur. J. Pharmacol. 267, 335-341
28. 28 Dionisotti, S. et al. (1994) Br. J. Pharmacol. 112, 659-665
29. 29 Jacobson, K. A. et al. (1993) J. Med. Chem. 36, 1333-1342
30. 30 Del Giudice, M. R. et al. (1996) Eur. J. Med. Chem. 31, 59-63
31. 31 Francis, J. E. et al. (1988) J. Med. Chem. 31, 1014-1020
32. 32 Zocchi, C. et al. (1996) J. Pharmacol. Exp. Ther. 276, 398-404
33. 33 Sarges, R. et al. (1990) J. Med. Chem. 33, 2240-2254
34. 34 Gatta, F. et al. (1993) Eur. J. Med. Chem. 28, 569-577
35. 35 Baraldi, P. G. et al. (1994) Bioorg. Med. Chem. Lett. 4, 2539-2544
36. 36 Baraldi, P. G. et al. (1996) J. Med. Chem. 39, 1164-1171
37. 37 Poucher, M. G. et al. (1995) Br. J. Pharmacol. 115, 1096-1102
38. 38 Kim, J., Wess, J., van Rhee, A. M., Schöneberg, T. and Jacobson, K. A. (1995) J. Biol. Chem. 270, 13987-13997
39. 39 Jiang, Q. et al. (1996) Mol. Pharmacol. 50, 512-521
40. 40 Zhang, Y. and Fredholm, B. B. (1994) Biochem. Pharmacol. 48, 2025-2032
41. 41 Nonaka, H. et al. (1994) Mol. Pharmacol. 46, 817-822
42. 42 Palmer, T. M., Poucher, S. M. Jacobson, K. A. and Stiles, G. L. (1995) Mol. Pharmacol. 48, 970-974
43. 43 Zocchi, C., Origini, E., Ferrara, S., Baraldi, P. G. and Dionisotti, S. (1996) Br. J. Pharmacol. 117, 1381-1386
44. 44 Dionisotti, S., Ferrara, S., Molta, C., Zocchi, C. and Ongini, E. (1996) J. Pharmacol. Exp. Ther. 278, 1209-1214
45. 45 Belardinelli, L. et al. Circ. Res. (in press)
46. 46 Keddie, J. R., Poucher, S. M., Shaw, G. R., Brooks, R. and Collis, M. G. (1996) Eur. J. Pharmacol. 301, 107-113
47. 47 Poucher, S. M. (1996) J. Physiol. 492, 495-503
48. 48 Jackson, E. K., Herzer, W. A. and Suzuki, F. (1993) J. Pharmacol. Exp. Ther. 267, 1304-1310
49. 49 Kanda, T., Shiozaki, S., Shimada, J., Suzuki, F. and Nakamura, J. (1994) Eur. J. Pharmacol. 56, 263-268
50. 50 Stone-Elander, S., Thorell, J-O., Ingvar, M., Eriksson, L. and Fredholm, B. B. (1995) J. Label. Comp. Radiopharm. 37, 389-390
51. 51 Bertorelli, R., Ferri, N., Adami, M. and Ongini, E. (1996) Drug Dev. Res. 37, 65-72
52. 52 Pinna, A., Di Chiara, G., Wardas, J. and Morelli, M. (1996) Eur. J. Neurosci. 8, 1176-1181
53. 53 Williams, M. (1995) in Psychopharmacology: The Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., eds), pp. 643-655, Raven Press
54. 54 Von Lubitz, D. K. J. E., Lin, R. C. S. and Jacobson, K. A. (1995) Eur. J. Pharmacol. 287, 295-302
55. 55 Phillis, J. W. (1995) Brain Res. 705, 79-84
56. 56 Rudolphi, K., Schubert, P., Parkinson, F. E. and Fredholm, B. B. (1992) Trends Pharmacol. Sci. 13, 439-445
57. 57 Johansson, B., Georgiev, V., Parkinson, F. E. and Fredholm, B. B. (1993) Eur. J. Pharmacol. Mol. Pharmacol. Sect. 247, 103-110
58. 58 Bruns, R. F. et al. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 64-69
59. 59 Ji, X. D., Stiles, G. L., van Galen, P. J. M. and Jacobson, K. A. (1992) J. Recept. Res. 12, 149-169
60. 60 Ukena, D. Jacobson, K. A., Kirk, K. L. and Daly, J. W. (1986) FEBS Lett. 199, 269-274